Skip to content
2000
Volume 8, Issue 3
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Bromodeoxyuridine (BrdU) is widely used for labeling dividing cells to determine their fate. In particular, the analysis of neurogenesis in the adult mammalian brain has made significant progress through the use of this technique. However; when using BrdU for labeling, there are several issues to consider in order to minimalize possible cytotoxicity or false-positive labeling. This current review summarizes methodological and technical aspects of BrdU administration and detection, compares alternative methods and gives recommendations on how to avoid labeling artifacts.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/138920107780906531
2007-06-01
2025-07-09
Loading full text...

Full text loading...

/content/journals/cpb/10.2174/138920107780906531
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test